Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug 27:10:405.
doi: 10.1186/1471-2164-10-405.

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients

Christiaan G J Saris  1 , Steve Horvath, Paul W J van Vught, Michael A van Es, Hylke M Blauw, Tova F Fuller, Peter Langfelder, Joseph DeYoung, John H J Wokke, Jan H Veldink, Leonard H van den Berg, Roel A Ophoff
Affiliations

Weighted gene co-expression network analysis of the peripheral blood from Amyotrophic Lateral Sclerosis patients

Christiaan G J Saris et al. BMC Genomics. .

Abstract

Background: Amyotrophic Lateral Sclerosis (ALS) is a lethal disorder characterized by progressive degeneration of motor neurons in the brain and spinal cord. Diagnosis is mainly based on clinical symptoms, and there is currently no therapy to stop the disease or slow its progression. Since access to spinal cord tissue is not possible at disease onset, we investigated changes in gene expression profiles in whole blood of ALS patients.

Results: Our transcriptional study showed dramatic changes in blood of ALS patients; 2,300 probes (9.4%) showed significant differential expression in a discovery dataset consisting of 30 ALS patients and 30 healthy controls. Weighted gene co-expression network analysis (WGCNA) was used to find disease-related networks (modules) and disease related hub genes. Two large co-expression modules were found to be associated with ALS. Our findings were replicated in a second (30 patients and 30 controls) and third dataset (63 patients and 63 controls), thereby demonstrating a highly significant and consistent association of two large co-expression modules with ALS disease status. Ingenuity Pathway Analysis of the ALS related module genes implicates enrichment of functional categories related to genetic disorders, neurodegeneration of the nervous system and inflammatory disease. The ALS related modules contain a number of candidate genes possibly involved in pathogenesis of ALS.

Conclusion: This first large-scale blood gene expression study in ALS observed distinct patterns between cases and controls which may provide opportunities for biomarker development as well as new insights into the molecular mechanisms of the disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gene co-expression modules in human whole blood. Detection of gene co-expression modules in human whole blood datasets comprised of ALS patients and matched controls. (a) Branches of the cluster dendrogram of the most connected genes gave rise to five gene coexpression modules (Blue, Green, Red, Turquoise and Yellow). Genes that could not be clustered into one of these modules were assigned to the Grey module. Every gene represents a line in the hierarchical cluster. Distance between two genes is shown as height on the y-axis. (b) Boxplots showing gene significance per module. Module significance was calculated by taking the average of the absolute t statistics of all genes within a module. The Blue and Yellow module were the only modules that were significant at a Bonferroni corrected significance threshold of 0.05/5 in all 3 datasets.
Figure 2
Figure 2
Scatterplots showing strong preservation of gene significance across the three independent datasets. The scatterplots include the network genes colored by their module assignment in dataset 1. t-test statistic value for dataset 1 (x-axis) was compared to the t statistic value for dataset 2 (y-axis A) and dataset 3 (y-axis B). Genes that are highly differentially expressed in dataset 1 also tend to be differentially expressed in datasets 2 and 3. Note that Blue genes tend to be over-expressed in ALS patients while yellow genes tend to be under-expressed.
Figure 3
Figure 3
Network of hub genes in the Yellow module colored by gene ontology functional information. Hub genes are connected by an edge if the correlation between their expression profiles is significant.
Figure 4
Figure 4
Network of hub genes in the Blue module colored by gene ontology functional information. Hub genes are connected by an edge if the correlation between their expression profiles is significant.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
    Levine AJ, Miller JA, Shapshak P, Gelman B, Singer EJ, Hinkin CH, Commins D, Morgello S, Grant I, Horvath S. Levine AJ, et al. BMC Med Genomics. 2013 Feb 13;6:4. doi: 10.1186/1755-8794-6-4. BMC Med Genomics. 2013. PMID: 23406646 Free PMC article.
  • Biological networks and complexity in early-onset motor neuron diseases.
    Butchbach MER, Scott RC. Butchbach MER, et al. Front Neurol. 2022 Oct 21;13:1035406. doi: 10.3389/fneur.2022.1035406. eCollection 2022. Front Neurol. 2022. PMID: 36341099 Free PMC article.
  • SMA-MAP: a plasma protein panel for spinal muscular atrophy.
    Kobayashi DT, Shi J, Stephen L, Ballard KL, Dewey R, Mapes J, Chung B, McCarthy K, Swoboda KJ, Crawford TO, Li R, Plasterer T, Joyce C; Biomarkers for Spinal Muscular Atrophy Study Group; Chung WK, Kaufmann P, Darras BT, Finkel RS, Sproule DM, Martens WB, McDermott MP, De Vivo DC; Pediatric Neuromuscular Clinical Research Network; Walker MG, Chen KS. Kobayashi DT, et al. PLoS One. 2013;8(4):e60113. doi: 10.1371/journal.pone.0060113. Epub 2013 Apr 2. PLoS One. 2013. PMID: 23565191 Free PMC article.
  • Common variant at 16p11.2 conferring risk of psychosis.
    Steinberg S, de Jong S, Mattheisen M, Costas J, Demontis D, Jamain S, Pietiläinen OP, Lin K, Papiol S, Huttenlocher J, Sigurdsson E, Vassos E, Giegling I, Breuer R, Fraser G, Walker N, Melle I, Djurovic S, Agartz I, Tuulio-Henriksson A, Suvisaari J, Lönnqvist J, Paunio T, Olsen L, Hansen T, Ingason A, Pirinen M, Strengman E; GROUP; Hougaard DM, Orntoft T, Didriksen M, Hollegaard MV, Nordentoft M, Abramova L, Kaleda V, Arrojo M, Sanjuán J, Arango C, Etain B, Bellivier F, Méary A, Schürhoff F, Szoke A, Ribolsi M, Magni V, Siracusano A, Sperling S, Rossner M, Christiansen C, Kiemeney LA, Franke B, van den Berg LH, Veldink J, Curran S, Bolton P, Poot M, Staal W, Rehnstrom K, Kilpinen H, Freitag CM, Meyer J, Magnusson P, Saemundsen E, Martsenkovsky I, Bikshaieva I, Martsenkovska I, Vashchenko O, Raleva M, Paketchieva K, Stefanovski B, Durmishi N, Pejovic Milovancevic M, Lecic Tosevski D, Silagadze T, Naneishvili N, Mikeladze N, Surguladze S, Vincent JB, Farmer A, Mitchell PB, Wright A, Schofield PR, Fullerton JM, Montgomery GW, Martin NG, Rubino IA, van Winkel R, Kenis G, De Hert M, Réthelyi JM, Bitter I, Terenius L, Jönsson EG, Bakker S, van Os J, Jablensky A, Leboyer M, Bramon E, Pow… See abstract for full author list ➔ Steinberg S, et al. Mol Psychiatry. 2014 Jan;19(1):108-14. doi: 10.1038/mp.2012.157. Epub 2012 Nov 20. Mol Psychiatry. 2014. PMID: 23164818 Free PMC article.
  • Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway.
    Mougeot JL, Li Z, Price AE, Wright FA, Brooks BR. Mougeot JL, et al. BMC Med Genomics. 2011 Oct 25;4:74. doi: 10.1186/1755-8794-4-74. BMC Med Genomics. 2011. PMID: 22027401 Free PMC article.
See all "Cited by" articles

References

    1. Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry. 2005;76:1046–1057. doi: 10.1136/jnnp.2004.048652. - DOI - PMC - PubMed
    1. Dunckley T, Huentelman MJ, Craig DW, Pearson JV, Szelinger S, Joshipura K, Halperin RF, Stamper C, Jensen KR, Letizia D, et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N Engl J Med. 2007;357:775–788. doi: 10.1056/NEJMoa070174. - DOI - PubMed
    1. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, Gibbs JR, Lombardo F, Matarin M, Kasperaviciute D, Hernandez DG, et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2007;6:322–328. doi: 10.1016/S1474-4422(07)70037-6. - DOI - PubMed
    1. van Es MA, Van Vught PW, Blauw HM, Franke L, Saris CG, Andersen PM, Bosch L Van Den, de Jong SW, van 't Slot R, Birve A, et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007;6:869–877. doi: 10.1016/S1474-4422(07)70222-3. - DOI - PubMed
    1. Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet. 2008;17:768–774. doi: 10.1093/hmg/ddm361. - DOI - PubMed

Publication types